Breaking News Instant updates and real-time market news.

NBIX

Neurocrine

$43.07

-1.93 (-4.29%)

09:06
10/13/16
10/13
09:06
10/13/16
09:06

Neurocrine recent weakness unwarranted, says BMO Capital

BMO Capital analyst M. Ian Somaiya says that Neurocrine (NBIX) has been weak recently in the wake of Myovant's S-1 filing. According to the analyst, investors view Myovant's relugolix as a more convenient alternative to Neurocrine's elagolix. However, the analyst thinks that relugolix's longer half-life "could complicate add-back therapy," while the wording of the questionnaire for relugolix's Phase 3 trial increases endometriosis clinical development risk. Additionally, the analyst says that Neurocrine's elagolix has a two to three year lead time over relugolix, setting the stage for both drugs to do well. He keeps a $66 price target and Outperform rating on Neurocrine.

  • 06

    Nov

  • 29

    Nov

  • 14

    Dec

NBIX Neurocrine
$43.07

-1.93 (-4.29%)

10/12/16
LEER
10/12/16
NO CHANGE
Target $70
LEER
Outperform
Neurocrine recent selloff a buying opportunity, says Leerink
Leerink analyst Paul Matteis views the 18% pullback in shares of Neurocrine Biosciences (NBIX) over the past few weeks as a buying opportunity. The analyst finds the catalyst for the selloff "difficult to pinpoint," but notes he's been receiving questions from investors on the size of the market opportunity for vesicular monoamine transporters in Tardive Dyskinesia. A doctor survey suggests a target market of 300,000 TD patients for Neurocrine's and Teva's VMAT2 inhibitors, which is enough to offer a "significant revenue opportunity" for both drugs, Matteis tells investors in a research note. Further, the analyst believes the upcoming Phase II data in Tourette's Syndrome, which he sees as having a high probability of success, offers a "nice catalyst for investors" into Q1 of next year. Matteis reiterates an Outperform rating on Neurocrine with a $70 price target.
10/06/16
LEHM
10/06/16
DOWNGRADE
Target $50
LEHM
Equal Weight
Alnylam downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Geoff Meacham downgraded Alnylam Pharmaceuticals (ALNY) to Equal Weight saying he views other SMid cap biotech names as more attractive following the company's recent pipeline setbacks. The analyst removed Revusiran sales from his Alnylam model after the program was discontinued yesterday and he cut his price target for the shares to $50 from $85. Meacham lists Neurocrine (NBIX), Prothena (PTRA) and Incyte (INCY) as names he finds more attractive over the next 12 months. Alnylam is trading down 44% in pre-market trading to $39.25.
10/04/16
LEER
10/04/16
INITIATION
Target $70
LEER
Outperform
Neurocrine reinstated with an Outperform at Leerink
Leerink analyst Paul Matteis resumed coverage of Neurocrine with an Outperform rating and $70 price target.
09/23/16
LEER
09/23/16
NO CHANGE
LEER
Outperform
Positive data paves way for Teva SD-809 indication, says Leerink
Leerink analyst Jason Gerberry says the AIM-TD study readout clinically de-risks Teva's (TEVA) SD-809 opportunity for tardive dyskinesia, with the investor focus shifting to market size and competitive differentiation versus Neurocrine's (NBIX) valbenazine. The analyst believes Teva's SD-809 is well positioned to compete against valbenazine with an equally efficacious and well tolerated drug. Further, he expects Teva to exit 2017 with a broader label. Gerberry reiterates an Outperform rating on Teva's shares.

TODAY'S FREE FLY STORIES

WMT

Wal-Mart

$72.14

0.43 (0.60%)

, TGT

Target

$65.62

-0.32 (-0.49%)

15:35
02/23/17
02/23
15:35
02/23/17
15:35
Periodicals
Trump supportive of border tax in Reuters interview »

Headlines crossing…

WMT

Wal-Mart

$72.14

0.43 (0.60%)

TGT

Target

$65.62

-0.32 (-0.49%)

HD

Home Depot

$145.17

-0.081 (-0.06%)

LOW

Lowe's

$76.40

-0.4 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

  • 01

    Mar

  • 05

    Mar

  • 06

    Mar

  • 14

    Mar

  • 15

    Mar

  • 19

    Mar

OLED

Universal Display

$71.25

-0.3 (-0.42%)

15:35
02/23/17
02/23
15:35
02/23/17
15:35
Options
Universal Display options imply 12.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 22

    Mar

  • 23

    Mar

  • 24

    Mar

15:35
02/23/17
02/23
15:35
02/23/17
15:35
Hot Stocks
Breaking Hot Stocks news story  »

Harmony Merger trading…

HRMN

Harmony Merger Corp.

$10.24

0.0499 (0.49%)

15:35
02/23/17
02/23
15:35
02/23/17
15:35
Hot Stocks
Breaking Hot Stocks news story on Harmony Merger Corp. »

Harmony Merger Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORI

Old Republic

$20.95

-0.07 (-0.33%)

15:27
02/23/17
02/23
15:27
02/23/17
15:27
Hot Stocks
Old Republic raises dividend, extends shareholder rights plan, expands board »

Old Republic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$8.46

-0.12 (-1.40%)

15:26
02/23/17
02/23
15:26
02/23/17
15:26
Options
SunPower call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXMD

TherapeuticsMD

$5.73

0.06 (1.06%)

15:24
02/23/17
02/23
15:24
02/23/17
15:24
Recommendations
TherapeuticsMD analyst commentary  »

TherapeuticsMD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 01

    Mar

  • 21

    Mar

  • 07

    May

USB

U.S. Bancorp

$55.38

0.07 (0.13%)

15:20
02/23/17
02/23
15:20
02/23/17
15:20
Periodicals
Trump considers outgoing U.S. Bancorp CEO for Fed board seat, Bloomberg says »

President Trump is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

  • 15

    Mar

CENX

Century Aluminum

$14.48

-0.77 (-5.05%)

15:20
02/23/17
02/23
15:20
02/23/17
15:20
Options
Century Aluminum options imply 12.4% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

ICPT

Intercept

$122.79

-2.66 (-2.12%)

15:19
02/23/17
02/23
15:19
02/23/17
15:19
Recommendations
Intercept analyst commentary  »

Intercept shares defended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 06

    Mar

$NSD

NASDAQ Market Internals

15:18
02/23/17
02/23
15:18
02/23/17
15:18
Technical Analysis
NASDAQ Market Internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:17
02/23/17
02/23
15:17
02/23/17
15:17
Technical Analysis
NYSE Market Internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VASC

Vascular Solutions

, TFX

Teleflex

$183.34

-0.67 (-0.36%)

15:16
02/23/17
02/23
15:16
02/23/17
15:16
Hot Stocks
Gabelli liquidates stake in Vascular Solutions »

As a result of the…

VASC

Vascular Solutions

TFX

Teleflex

$183.34

-0.67 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

UPS

UPS

$105.01

-0.615 (-0.58%)

15:12
02/23/17
02/23
15:12
02/23/17
15:12
Hot Stocks
Teamsters says UPS mechanics seek mediation release »

The Teamsters union…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

KMI

Kinder Morgan

15:11
02/23/17
02/23
15:11
02/23/17
15:11
Options
Notable call buying in Kinder Morgan »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$80.74

1.12 (1.41%)

15:06
02/23/17
02/23
15:06
02/23/17
15:06
Hot Stocks
Medtronic reports presentation of data on Solitaire stent retriever »

Medtronic said data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 07

    Mar

  • 17

    Mar

  • 21

    Mar

ACIA

Acacia Communications

$62.22

-4.32 (-6.49%)

15:05
02/23/17
02/23
15:05
02/23/17
15:05
Options
Acacia Communications options imply 14.2% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 04

    Apr

  • 05

    Apr

HRMN

Harmony Merger Corp.

$10.24

0.0499 (0.49%)

15:04
02/23/17
02/23
15:04
02/23/17
15:04
Hot Stocks
Harmony Merger receives termination of merger pact from MUNDOmedia »

Harmony Merger announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLD

Prologis

$50.26

-0.08 (-0.16%)

15:02
02/23/17
02/23
15:02
02/23/17
15:02
Hot Stocks
Prologis raises annualized dividend level by 5% to $1.76 per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

FDX

FedEx

$191.42

-2.4099 (-1.24%)

15:01
02/23/17
02/23
15:01
02/23/17
15:01
Hot Stocks
FedEx extends relationship with Joe Gibbs Racing »

FedEx announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 06

    Mar

KATE

Kate Spade

$23.60

-0.24 (-1.01%)

15:01
02/23/17
02/23
15:01
02/23/17
15:01
Options
In the money call buying in Kate Spade »

In the money call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TANH

Tantech Holdings

$1.80

-0.04 (-2.17%)

15:00
02/23/17
02/23
15:00
02/23/17
15:00
Hot Stocks
Tantech Holdings CEO sees operating profits growing 'substantially faster' »

Tantech Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
02/23/17
02/23
15:00
02/23/17
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

CME

CME Group

$122.51

1.46 (1.21%)

14:59
02/23/17
02/23
14:59
02/23/17
14:59
Hot Stocks
CME Group reports new record for Fed Fund futures contracts »

CME Group announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

PI

Impinj

$28.49

-0.34 (-1.18%)

14:57
02/23/17
02/23
14:57
02/23/17
14:57
Technical Analysis
Impinj spikes higher, levels to watch »

Shares were last up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

  • 22

    Mar

  • 23

    Mar

  • 24

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.